EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid

Sarah Sedik, Johannes Boyer, Matthias Egger, Karl Dichtl, Juergen Prattes, Florian Prüller, Martin Hoenigl

Mycopathologia · 2024

DOI: 10.1007/s11046-024-00876-9 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Mycopathologia, 2024. Verfasst von Sarah Sedik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, ECMM Excellence Center, Auenbruggerplatz 15, 8036, Graz…. Hauptthemen laut MEDLINE: Mannans, Galactose, Bronchoalveolar Lavage Fluid, Invasive Pulmonary Aspergillosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IMMY Investigator Initiated Research, Medical University of Graz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Galactomannan (GM) testing using Platelia Aspergillus enzyme immunoassay (Platelia AGM) from bronchoalveolar lavage fluid (BALF) aids in early diagnosis of invasive pulmonary aspergillosis (IPA). Globally, only a minority of laboratories have the capability to perform on-site GM testing, necessitating accessible and affordable alternatives. Hence, we conducted a comparative evaluation of the new clarus Aspergillus GM enzyme immunoassay prototype (clarus AGM prototype) with Platelia AGM using BALF samples.

Methods

This is a single-center, prospective, cross-sectional study, where Platelia AGM testing was routinely performed followed by clarus AGM prototype testing in those with true positive or true negative AGM test results according to the 2020 EORTC/MSG and the 2024 FUNDICU consensus definitions. Descriptive statistics, ROC curve analysis, and Spearman’s correlation analysis were used to evaluate analytical performance of the clarus AGM prototype assay.

Results

This study enrolled 259 adult patients, of which 53 (20%) were classified as probable IPA, while 206 did not fulfill IPA-criteria. Spearman's correlation analysis revealed a strong correlation between the two assays (rho = 0.727, p < 0.001). The clarus AGM prototype had a sensitivity of 96% (51/53) and a specificity of 74% (153/206) for differentiating probable versus no IPA when using the manufacturer recommended cut-off. ROC curve analysis showed an AUC of 0.936 (95% CI 0.901–0.971) for the clarus AGM prototype, while the Platelia AGM yielded an AUC of 0.918 (95% CI 0.876–0.959).

Conclusions

Clarus AGM prototype demonstrated a strong correlation and promising test performance, comparable to Platelia AGM, rendering it a viable alternative in patients at risk of IPA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MannansGalactoseBronchoalveolar Lavage FluidInvasive Pulmonary AspergillosisImmunoenzyme TechniquesAspergillusSensitivity and SpecificityHumansProspective StudiesCross-Sectional StudiesMiddle AgedMaleFemaleAdultAgedROC CurveYoung Adult

Stichwörter der Autor:innen

BALFDiagnosticsEnzyme-linked immunoassayGalactomannanInvasive pulmonary aspergillosis

Substanzen

MannansGalactosegalactomannan

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, ECMM Excellence Center, Auenbruggerplatz 15, 8036, Graz, Austria.
  • Translational Mycology, Medical University of Graz, Graz, Austria.
  • Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
  • Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, ECMM Excellence Center, Auenbruggerplatz 15, 8036, Graz, Austria. juergen.prattes@medunigraz.at.
  • Translational Mycology, Medical University of Graz, Graz, Austria. juergen.prattes@medunigraz.at.
  • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

Förderung

  • IMMY Investigator Initiated Research
  • Medical University of Graz

Zitieren

APA

Sedik, S., Boyer, J., Egger, M., Dichtl, K., Prattes, J., Prüller, F., & Hoenigl, M. (2024). Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid. Mycopathologia. https://doi.org/10.1007/s11046-024-00876-9

Vancouver

Sedik S, Boyer J, Egger M, Dichtl K, Prattes J, Prüller F, et al. Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid. Mycopathologia. 2024. doi:10.1007/s11046-024-00876-9

BibTeX
@article{Sedik2024,
  author = {Sedik, Sarah and Boyer, Johannes and Egger, Matthias and Dichtl, Karl and Prattes, Juergen and Prüller, Florian and Hoenigl, Martin},
  title = {Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid},
  journal = {Mycopathologia},
  year = {2024},
  doi = {10.1007/s11046-024-00876-9}
}
Kostenlos starten →